drugset / Trial / NCT02560467
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
NaSingle-groupOpen-labelDiagnostic
Summary
The objective of this study is to determine whether myocardial contrast echocardiography in patients with cardiomyopathy (HCM) can detect resting hypo-perfusion due to fibrosis or stress induced perfusion defects due to associated abnormalities in intramyocardial arteries and the microcirculation. A secondary aim will be to determine whether abnormalities in perfusion are associated with either severity of symptoms (chest pain and dyspnea), presence of arrhythmias, and regional function of the septum.
Timeline
- Start
- 2015-12-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Definity | Diagnostic / imaging agent | — | Intravenous |
| Background | Lumason | Diagnostic / imaging agent | — | Intravenous |
| Background | Regadenoson | Diagnostic / imaging agent | — | — |